NINA (NICKI) LOCKER

Nicki Locker specializes in securities litigation. She has represented companies and their officers and directors in more than 75 shareholder class actions and derivative suits throughout the United States.

Nicki also has extensive experience in corporate internal investigations and SEC investigations and enforcement proceedings. She has advised numerous boards and special committees in internal investigations regarding accounting improprieties, FCPA violations, stock option backdating, insider trading, off-label marketing, and embezzlement. Nicki has represented over 20 companies in government investigations and has served as personal counsel to dozens of executives and directors in SEC matters.

In 2003, Stanford Lawyer featured Nicki in its cover article "Do the Right Thing," which discusses how securities litigation has changed in recent years and how Nicki is helping clients implement systems to detect fraud and improve corporate governance practices.

After graduating from Stanford Law School in 1984, Nicki clerked for the Honorable Anthony Kennedy of the U.S. Court of Appeals for the Ninth Circuit. Nicki has been at Wilson Sonsini Goodrich & Rosati since 1985. She is a member of the firm's Policy Committee and has chaired the Nominating Committee.

Representation of a communications and networking company in internal investigation regarding potential FCPA violations

Audit Committee of a public company in internal investigation regarding potential violations of the related party transaction disclosure rules

Audit Committee of Ixia in internal investigation regarding accounting for multi-element transactions and post-contract support transactions

Special Committee of Board of Directors of a public technology company in internal investigation regarding stock sales by several officers and directors

Special Review Committee of a public IT infrastructure company in internal investigation regarding stock options

Audit Committee of a public company in internal investigation regarding off-label promotion of FDA-approved medication

Juniper Networks in SEC investigation regarding multi-year financial restatement relating to accounting for stock options. Investigation concluded with a settlement that did not include any monetary fine.

Former CFO and CEO of a public company after the SEC enforcement staff recommended charging client with securities fraud violations. SEC concluded investigation without filing any charges.

Public company in SEC investigation regarding potential FCPA violations

Former Audit Committee chairman of public company after SEC recommended charging client with securities fraud violations. SEC concluded matter without filing any enforcement action.

Critical Path in SEC investigation relating to multi-year financial restatement. Investigation concluded with a settlement that did not include any monetary penalties or fraud claims.

Special Committees of several public companies in internal investigations regarding stock option practices, revenue recognition, and expense and reserve issues